The following video is from Friday's Motley Fool Money roundtable discussion, in which host Chris Hill, and analysts Jason Moser, James Early, and Matt Koppenheffer discuss the top business and investing stories of the week.
The Dow hit another record high this week. Are stocks getting too pricey? Are there still values to be found? In this installment of Motley Fool Money, our analysts take stock in the stock market's new highs.
The best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report, "3 Stocks That Will Help You Retire Rich," names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of.�Click here now�to keep reading.
The relevant video segment can be found between 0:24 and 3:06.
For the full video of today's Motley Fool Money, click here.
Top 10 Quality Stocks To Invest In 2016: MGT Capital Investments Inc (MGT)
MGT Capital Investments, Inc (MGT), incorporated in 1977, is a holding company. As of December 31, 2011, the Company was analyzing potential acquisition opportunities in healthcare marketing and technology, as well as various intellectual property assets. The Company has a controlling interest in Medicsight ltd (Medicsight) and its subsidiaries Medicsight, Inc., Medicsight KK (Japan), Medicsight Pty Limited (Australia), Medicsight FZE (UAE), MedicEndo Limited (UAE), MedicCO2lon Limited (UAE) and Medicsight UK Limited (UK). The Company also have wholly owned subsidiaries MGT Capital Investments (UK) Limited, MGT Investments (Gibraltar) Limited, and Medicsight. Medicsight and its wholly owned subsidiaries is a medical technology company focusing on medical imaging software development and medical hardware devices. On March 29, 2011 the Company disposed of its 49% holding in Moneygate Group Limited (Moneygate). In September 2013, MGT Capital Investments, Inc MGT Interactive, LLC acquired certain assets from Gioia Systems LLC.
Medicsight�� core technology is the ColonCAD algorithm that is integrated (using application protocol interface (API) technology) into visualization workstations for radiologists to use when reviewing a patient�� colon computer tomography (CT) scan data. The computer-aided detection (CAD) algorithm assists the radiologist as they search for polyps in the CT scan image data. The radiologist uses the visualization software to review the patient�� CT scan images on the screen and searches for polyps (potentially pre-cancerous lesions on the wall of the colon). After a full review, the radiologist then activates the Medicsight ColonCAD software, which immediately displays CAD marks on the images, drawing the radiologist�� attention to potential polyps and other regions of interest. The radiologist then assesses each marked region in order to make the final decision as to the presence or absence of a polyp.
In addition to the computer aided detection so! ftware applications, Medicsight has developed an automated carbon dioxide (CO2) insufflation device, MedicCO2LON. A patient undergoing a CT colon scan requires the colon to be insufflated (distended) with either CO2 gas or room air administered prior to the acquisition of their CT colonography images. MedicCO2LON is designed to provide insufflation, for the acquisition of images from the CT colonography examination.
The Company competes with GE, Hitachi, Philips, Siemens and Toshiba.
Advisors' Opinion:- [By Markman Advisors]
Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).
Hot Long Term Companies To Watch In Right Now: MEDL Mobile Holdings Inc (MEDL)
MEDL Mobile Holdings, Inc. incorporated on May 22, 2008 is a developer, incubator, marketer and aggregator of mobile application software (Apps). The Company is engaged in the monetization of mobile application software through four revenue generating platforms: development of customized Apps for third parties to monetize their particular intellectual property, persona or brand, incubation of Apps in partnership with third parties and from a library of more than 75,000 original Apps concept submissions, sale of advertising and sponsorship opportunities directly to brands via mobile advertising networks and acquisition of Apps from other developers and use of a application programming interface ( API).
The Company develops Apps for customers that vary in size from small start-ups to large multinational corporations, in a range of industries including retailing, fast food, air travel, medical devices, higher education and fashion. As of December 31, 2011, revenues its custom development accounted for approximately 93% of its total revenues. The Company prepares packages for sale in the Apple App Store and the Google Android Marketplace. This package includes app store copy, sample screen shots.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Digital Caddies Inc (OTCMKTS: CADY), MEDL Mobile Holdings Inc (OTCMKTS: MEDL) and Yappn Corp (OTCMKTS: YPPN) offer different ways to potentially profit from Internet or mobile technology. However, all three small cap stocks have also been the subject of paid promotions or investor relations types of activities. So will investors actually profit from the efforts of these small caps to profit from the Internet or mobile technology? Here is a quick reality check:
Hot Long Term Companies To Watch In Right Now: Pharmaxis Ltd (PXS)
Pharmaxis Ltd is a pharmaceutical company that researches, develops and commercializes therapies for undertreated respiratory diseases. Its therapeutic interests include lung diseases such as cystic fibrosis, bronchiectasis and asthma, as well as chronic obstructive pulmonary diseases such as chronic bronchitis and pulmonary fibrosis. The Company�� products include Aridol and Bronchitol. The Company�� Aridol product is a lung function test. The product is designed to identify twitchy or hyper-responsive airways and to assist in diagnosing and managing asthma. Aridol is approved for sale in Australia, European countries, South Korea and the United States. is a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions. The Company develops Bronchitol for diseases including cystic fibrosis, bronchiectasis and chronic bronchitis. Advisors' Opinion:- [By Trista Kelley]
Science in Sport Ltd. broke away from its parent company, Provexis Plc (PXS), and began trading today after an initial public offering as the maker of nutritional sports gels rides a surge in Britain�� Lycra-clad cyclists.
Hot Long Term Companies To Watch In Right Now: Coca Cola Femsa S.A.B. de C.V. (KOF)
Coca Cola FEMSA, S.A.B. de C.V. produces, markets, and distributes Coca-Cola trademark beverages and brands. It offers colas under Coca-Cola, Coca-Cola Light, and Coca-Cola Zero brands; flavored sparkling beverages under Aquarius Fresh, Chinotto, Crush, Fanta, Fresca, Frescolita, Hit, Kuat, Lift, Mundet, Quatro, Simba, and Sprite brands; water under Alpina, Brisa, Ciel, Crystal, Kin, Manantial, and Nevada brands; Aquarius, a flavored water; Hi-C, a juice-based beverage; and Powerade, an isotonic, as well as ready to drink tea products under Nestea and Matte Leao brands. The company also sells and distributes the Kaiser beer brand. It operates in Mexico, Central America, Colombia, Venezuela, Brazil, and Argentina. The company was founded in 1979 and is based in Mexico, Mexico. Coca-Cola FEMSA S.A.B de C.V. operates as a subsidiary of Fomento Economico Mexicano, S.A.B. de C.V.
Advisors' Opinion:- [By Eric Volkman]
Put another tick in the acquisition column for Coca-Cola FEMSA (NYSE: KOF ) . The Mexico-based company, which says it is the largest bottler of Coca-Cola products on the planet, has signed a deal to acquire Brazilian peer Companhia Fluminense de Refrigerantes. The price is $448 million in cash.
No comments:
Post a Comment